DOI:
10.1055/s-00029030
Journal of Pediatric Neurology
LinksClose Window
References
Whitford W, Hawkins I, Glamuzina E. et al.
Compound heterozygous SLC19A3 mutations further refine the critical promoter region for biotin-thiamine-responsive basal ganglia disease.
Cold Spring Harb Mol Case Stud 2017;
3 (06) a001909
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.